1. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive tion. We are adding to these preliminary data by studying a cohort of sibs. The significant difference between those patients drugs;Kinlen, L.J.; Sheil, A.G.R.; Peto, J.; Doll, R.;BrMedJ,1979
2. Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol;Barker, J.N.W.N.; MlacDonald, D.M.,1988
3. Regional distribution ot moles and still having treatment and those whose treatment was completed suggests that this effect is likely to be due to melanoma;Pack, G.T.; Lenson, N.; Gerber, D.M.;Arch Surg,1952
4. Development and elimination of pigmented moles, and the anatomical distribution of primary malignant melanoma. Cancer 1973; immunosuppression as a result of treatment rather than the underlying disease. Certain drugs included in the cytotoxic regimens of these patients (cyclophosphamide, doxorubicin, and daunorubicin) are known to cause generalised hyperpigmentation, but;Nicholls, E.M.
5. Frequency of moles in a defined population;Cooke, K.R.; Spears, G.F.S.; Skegg, D.C.G.;J Epidemiol Community Health,1985